Search for: "Henry v. Wyeth Pharmaceuticals" Results 1 - 20 of 30
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Dec 2020, 5:31 am by Annsley Merelle Ward
The main course – Supreme Court cases (7) Modified Mouse Surprise In Regeneron Pharmaceuticals v Kymab [2020] UKSC 27, the UK Supreme Court reviewed the principle of general application in relation to Regeneron’s patents for the creation of a range of types of transgenic mice that produce chimeric antibodies. [read post]
27 Mar 2019, 1:00 am by Thaddeus Mason Pope, JD, PhD
Pharmaceutical Pricing Jaime King, University of California Hastings College of the Law, The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs Marc Rodwin, Suffolk University Law School, Controlling Pharmaceutical Prices: What the U.S. [read post]
24 Oct 2014, 7:23 am by Second Circuit Civil Rights Blog
Wyeth Pharmaceuticals, which states:The district courts in this circuit have developed a standardized approach for applying these concepts to individual cases. [read post]
19 Mar 2013, 6:01 am by Joe Consumer
  In Wyeth v Levine, the Court pointed out that “Congress did not intend FDA oversight to be the exclusive means of ensuring drug safety and effectiveness’ and that state law serves as a ‘complementary form of drug regulation. [read post]
4 Jun 2011, 6:12 am by Walter Olson
Tags: Henry Waxman, obstetrics, pharmaceuticals Related posts Wyeth v. [read post]
21 Mar 2011, 5:59 am by Joe Consumer
Supreme Court believes a law like this is a bad thing for the country, as they ruled in the 2009 case in Wyeth v. [read post]
21 Mar 2011, 5:59 am by Joe Consumer
Supreme Court believes a law like this is a bad thing for the country, as they ruled in the 2009 case in Wyeth v. [read post]
3 Jan 2011, 9:45 pm by Law Lady
Pharmaceuticals: GLAXO AND SUBSIDIARY SETTLE CIVIL, CRIMINAL CASES FOR $750 MILLION, United States v. [read post]
2 Feb 2010, 7:28 am by Beck, et al.
The other side first argued, after Wyeth v. [read post]
1 Dec 2009, 9:39 am
KV Pharmaceutical Corp., 2008 WL 2937415 (D.N.J. 2008). [read post]